Image de ThisisEngineering RAEng

Management & Scientific Committee

 
JoelBesse_President_edited.jpg

Joël Besse, M.Sc., M.Sc.

President

Aerospace Engineer of ISAE Sup'aero and Master's degree from University of Toulouse. 
For 30 years venture capitalist (SED Ventures, Atlas Venture), Business Angel (Momentum Biotech), director (Actelion, Novexel, Novuspharma...), founder and consultant of biotech companies, medtech, foodtech and international venture capital funds.

Scientific committee

High-level experts in various complementary fields

Pharmaceutical • Addiction • Tobacco cancer • Clinical development

Prof. Carole Clair

Scientific Advisory Board

Dr. Clair is the current President of the Society for Research on Nicotine and Tobacco Europe (SRNT-E).
Graduate physician from the University of Lausanne (2002), FMH specialist in general internal medicine (2007), PhD thesis (MD) on the link between smoking and diabetes (2008).
After clinical training, completed a postdoctoral fellowship (2009-2011) at the Center for General Internal Medicine and Tobaccoology at Massachusetts General Hospital (Boston), training in clinical epidemiology (Harvard School of Public Health - Boston). Master of Science degree (2012).
In Switzerland, obtaining an FNS Ambizione grant (2015) to continue his research (stopping smoking in people with diabetes). Obtaining a Privat Docent and a CLINICAL title MER (2016), appointment as an assistant professor at the PMU (director of the research and development centre).

Prof. Paul Aveyard

Scientific Advisory Board

Associate Professor Ferguson is a health psychologist at the College of Health and Medicine School of Medicine at the University of Tasmania in Australia. He is primarily interested in health-related behaviour change (for example, quitting smoking, managing weight, etc.).
His main research interest is to explore the process and factors of relapse, especially in cigarette smokers. He is also interested in the effectiveness of treatment and the factors that influence the likelihood of treatment use and adherence to treatment in attempts to stop treatment. To explore these topics, Professor Assoc Ferguson uses a wide range of research methodologies, ranging from laboratory techniques to sophisticated field surveillance in near real time.

Prof. Scott Leischow

Scientific Advisory Board

Dr. Leischow is a past president of the Society for Research on Nicotine and Tobacco (SRNT) and founder and editor-in-chief of the journal Tobacco Regulatory Science.
He joined Arizona State University in June 2017, and is Professor and Director of Clinical and Translational Sciences. Previously, he was at the Arizona Mayo Clinic from 2012 to 2017, where he led the Health Equity and Community Health Research Program (REACH) and co-led cancer prevention and control. He was previously Associate Director at the University of Arizona Cancer Control Center and was also Head of the Tobacco Control Research Division at the National Cancer Institute and Senior Advisor for Tobacco Policy in the Office of the Secretary of the U.S. Department of Health and Human Services.
His research focuses on pharmacological and behavioural treatments for tobacco dependence, tobacco regulation and population health.

Dr. Mitch Nides

Scientific Advisory Board

Dr. Nides is the President of Los Angeles Clinical Trials, specializing in clinical research and the development of products and drugs to help smokers stop using burnt tobacco. Dr. Nides has been the lead investigator in more than 60 smoking cessation trials testing nicotine and nicotine-free products, including patches, gums, lozenges, inhalers, Zyban and varenicline.
From 1987 to 1999, Dr. Nides was a research researcher on smoking cessation in the Department of Lung and Critical Care at UCLA School of Medicine. Over the years, Dr. Nides has trained thousands of physicians, pharmacists, nurses and other health professionals on how to help their smokers quit.

Prof. Stuart Ferguson

Scientific Advisory Board

Associate Professor Ferguson is a health psychologist at the College of Health and Medicine School of Medicine at the University of Tasmania in Australia. He is primarily interested in health-related behaviour change (for example, quitting smoking, managing weight, etc.).
His main research interest is to explore the process and factors of relapse, especially in cigarette smokers. He is also interested in the effectiveness of treatment and the factors that influence the likelihood of treatment use and adherence to treatment in attempts to stop treatment. To explore these topics, Professor Assoc Ferguson uses a wide range of research methodologies, ranging from laboratory techniques to sophisticated field surveillance in near real time.